e-learning
resources
Vienna 2009
Sunday, 13.09.2009
Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Idiopathic interstitial lung disease with anti-ssa/ssb antibodies: a forme fruste of connective tissue disease?
J. F. Boitiaux, M. P. Debray, P. Nicaise-Roland, H. Adle-Biassette, C. Taille, M. Bonnay, S. Marchand-Adam, J. Cadranel, M. Aubier, B. Crestani (Paris, France)
Source:
Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease
Session:
Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease
Session type:
Thematic Poster Session
Number:
705
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. F. Boitiaux, M. P. Debray, P. Nicaise-Roland, H. Adle-Biassette, C. Taille, M. Bonnay, S. Marchand-Adam, J. Cadranel, M. Aubier, B. Crestani (Paris, France). Idiopathic interstitial lung disease with anti-ssa/ssb antibodies: a forme fruste of connective tissue disease?. Eur Respir J 2009; 34: Suppl. 53, 705
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Interstitial lung disease: are we missing formes frustes of connective tissue disease?
Source: Eur Respir J 2006; 28: 893-896
Year: 2006
Occult connective tissue diseases mimicking idiopathic interstitial pneumonias
Source: Eur Respir J 2008; 31: 11-20
Year: 2008
Idiopathic nonspecific interstitial pneumonia: an interstitial lung disease associated with autoimmune disorders?
Source: Eur Respir J 2011; 38: 384-391
Year: 2011
Significance of histopathologic features suggesting connective tissue disease in idiopathic pulmonary fibrosis
Source: International Congress 2015 – Connective tissue disorders
Year: 2015
Idiopathic non-specific interstitial pneumonia (iNSIP): do the patients develop connective tissue disease (CTD) during follow-up?
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
Significance of connective tissue disease features in idiopathic interstitial pneumonia
Source: Eur Respir J 2012; 39: 661-668
Year: 2012
Interstitial lung disease with autoimmune features
Source: Eur Respir Mon 2011; 54: 104-117
Year: 2011
ILD-India registry: Idiopathic pulmonary fibrosis (IPF) and connective tissue disease (CTD) associated interstitial lung disease (CTD-ILD)
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Dermato-pulmonary syndrome associated with MDA-5 antibodies: Report of the first French series
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Relevance of the expert ILD clinical-radiological evaluation of referred cases to the MDT
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Clinical analysis of lung manifestation in Sjögren's syndrome
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013
Constrictive (obliterative) bronchiolitis as presenting manifestation of connective tissue disease
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
Genomic comparison of fibrotic rheumatoid arthritis-associated ILD and idiopathic pulmonary fibrosis
Source: International Congress 2015 – Connective tissue disorders
Year: 2015
Tacrolimus for antisynthetase syndrome with interstitial lung disease?
Source: Eur Respir J 2008; 32: 244-245
Year: 2008
Clinical features of usual interstitial pneumonia-correlation between idiopathic pulmonary fibrosis and connective tissue disease associated with usual interstitial pneumonia
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
Novel markers of connective tissue disease in patients with idiopathic interstitial pneumonia
Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders
Year: 2008
Rituximab in severe, progressive interstitial lung disease
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
Clinical features of microscopic polyangiitis with usual interstitial pneumonia-like fibrosis in comparison with idiopathic pulmonary fibrosis
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
Idiopathic pulmonary fibrosis: a treatable disease?
Source: Eur Respir J 2003 Dec 01;22(6):872-873
Year: 2003
Hughes-Stovin syndrome: A case report
Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept